Extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome patients with and without heart failure: A prespecified subgroup analysis of the OPT-BIRISK trial
Extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome patients with and without heart failure: A prespecified subgroup analysis of the OPT-BIRISK trial. // Biophysical Reports. – URL: https://www.sciencedirect.com/science/article/pii/S0014299926009817?dgcid=rss_sd_all
Extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome patients with and without heart failure: A prespecified subgroup analysis of the OPT-BIRISK trial. Biophysical Reports. https://www.sciencedirect.com/science/article/pii/S0014299926009817?dgcid=rss_sd_all
“Extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome patients with and without heart failure: A prespecified subgroup analysis of the OPT-BIRISK trial.” Biophysical Reports.
@article{article11134,
title = {Extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome patients with and without heart failure: A prespecified subgroup analysis of the OPT-BIRISK trial},
journal = {Biophysical Reports},
url = {https://www.sciencedirect.com/science/article/pii/S0014299926009817?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Jun-Jie Zhang, Danni Colledge, Andrea Jurado, Ning Sun, Hu Zhang, Kathy Jackson, Vitina Sozzi, Xin Li, Nicholas S. Eyre, Michael R. Beard, Radhakrishnan...
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Sneha Singh, Arijit Vijey Jeyachandran, Maria Daskou, Anne Zaiss, Henry Kolge, Robert E. Wright, Anita Singhal, Anna Bonazzi, Robert Damoiseaux,...